Across TCGA pan-cancer cohorts, SCUBE1-AS1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SCUBE1-AS1’s most consistent transcriptional readouts.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where SCUBE1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SCUBE1-AS1 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.
LIHC, BRCA, and KIRC are the cancer types where SCUBE1-AS1 tumor–normal differential expression is most reproducible.